JFA
MNTA

JNBA Financial Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

JNBA Financial Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-100
Closed -$1K – 1527
2016
Q3 		$1K Buy
+100
New +$1.18K ﹤0.01% 1559

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JNBA Financial Advisors's MNTA Position: Q4 2016 in Review

JNBA Financial Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2016, closing a stake of 100 shares — an estimated $1K sold.

JNBA Financial Advisors first reported a position in MNTA in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 160 funds tracked by Wall St. Rank hold MNTA as of Q4 2016.

  • JNBA Financial Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • JNBA Financial Advisors sold 100 Momenta Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1K.
  • JNBA Financial Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2016 and held it in 1 quarter.
  • JNBA Financial Advisors's Momenta Pharmaceuticals, Inc. position peaked at $1K in Q3 2016.
  • 160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2016.

Based on JNBA Financial Advisors's 13F filing for Q4 2016, filed 3 Feb 2017.